USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 193 filers reported holding USANA HEALTH SCIENCES INC in Q4 2018. The put-call ratio across all filers is 6.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,487,000 | -77.7% | 94,232 | -71.6% | 0.00% | -80.0% |
| Q4 2021 | $33,634,000 | +7.6% | 332,344 | -2.0% | 0.01% | 0.0% |
| Q3 2021 | $31,267,000 | -13.0% | 339,117 | -3.3% | 0.01% | -16.7% |
| Q2 2021 | $35,923,000 | +19.4% | 350,708 | +13.8% | 0.01% | +20.0% |
| Q1 2021 | $30,091,000 | +7518.0% | 308,307 | +5913.4% | 0.01% | – |
| Q4 2020 | $395,000 | -46.7% | 5,127 | -49.1% | 0.00% | – |
| Q3 2020 | $741,000 | -29.3% | 10,069 | -29.4% | 0.00% | – |
| Q2 2020 | $1,048,000 | +195.2% | 14,270 | +131.9% | 0.00% | – |
| Q1 2020 | $355,000 | -90.8% | 6,154 | -86.6% | 0.00% | -100.0% |
| Q1 2019 | $3,855,000 | -13.9% | 45,954 | +20.8% | 0.00% | 0.0% |
| Q4 2018 | $4,478,000 | -11.4% | 38,031 | -9.3% | 0.00% | 0.0% |
| Q3 2018 | $5,056,000 | -45.4% | 41,937 | -47.8% | 0.00% | -50.0% |
| Q2 2018 | $9,260,000 | +24.3% | 80,315 | -7.4% | 0.00% | 0.0% |
| Q1 2018 | $7,449,000 | +16.0% | 86,724 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $6,422,000 | +28.4% | 86,724 | +0.1% | 0.00% | 0.0% |
| Q3 2017 | $5,000,000 | -0.8% | 86,647 | +10.2% | 0.00% | 0.0% |
| Q2 2017 | $5,038,000 | +47.1% | 78,603 | +32.2% | 0.00% | 0.0% |
| Q1 2017 | $3,424,000 | -5.9% | 59,456 | -0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,640,000 | -23.1% | 59,483 | +73.8% | 0.00% | 0.0% |
| Q3 2016 | $4,736,000 | +62.2% | 34,230 | +30.7% | 0.00% | 0.0% |
| Q2 2016 | $2,919,000 | +24.1% | 26,199 | +35.2% | 0.00% | 0.0% |
| Q1 2016 | $2,352,000 | -6.7% | 19,375 | -1.8% | 0.00% | 0.0% |
| Q4 2015 | $2,520,000 | +2.4% | 19,730 | +7.5% | 0.00% | 0.0% |
| Q3 2015 | $2,460,000 | -1.9% | 18,353 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $2,508,000 | +23.0% | 18,353 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $2,039,000 | +8.6% | 18,353 | +0.3% | 0.00% | – |
| Q4 2014 | $1,877,000 | +38.7% | 18,292 | -0.4% | 0.00% | – |
| Q3 2014 | $1,353,000 | +48.2% | 18,360 | +57.2% | 0.00% | – |
| Q2 2014 | $913,000 | -31.9% | 11,676 | -34.3% | 0.00% | – |
| Q1 2014 | $1,340,000 | +5.2% | 17,782 | +5.5% | 0.00% | – |
| Q4 2013 | $1,274,000 | -12.3% | 16,857 | +0.7% | 0.00% | – |
| Q3 2013 | $1,452,000 | +21.4% | 16,733 | +1.3% | 0.00% | – |
| Q2 2013 | $1,196,000 | – | 16,524 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
| Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
| Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
| ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
| Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
| Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
| Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
| Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
| CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
| JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |